VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 87 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $5,912,000 | -41.6% | 310,354 | -48.3% | 0.04% | -48.8% |
Q1 2018 | $10,116,000 | +57.0% | 600,354 | +41.6% | 0.09% | +53.6% |
Q4 2017 | $6,443,000 | -15.1% | 423,884 | 0.0% | 0.06% | -9.7% |
Q3 2017 | $7,588,000 | +45.9% | 423,884 | +3.4% | 0.06% | +34.8% |
Q2 2015 | $5,201,000 | -68.0% | 409,881 | -76.6% | 0.05% | -65.9% |
Q1 2015 | $16,277,000 | -74.6% | 1,750,230 | -60.9% | 0.14% | -79.4% |
Q4 2014 | $64,041,000 | +41.1% | 4,472,153 | +2.3% | 0.65% | +14.3% |
Q3 2014 | $45,383,000 | -35.8% | 4,372,153 | 0.0% | 0.57% | -33.9% |
Q2 2014 | $70,741,000 | -2.1% | 4,372,153 | -1.7% | 0.87% | -5.7% |
Q1 2014 | $72,243,000 | +21.5% | 4,445,696 | -7.2% | 0.92% | +9.5% |
Q4 2013 | $59,459,000 | +13.3% | 4,791,179 | 0.0% | 0.84% | +12.3% |
Q3 2013 | $52,463,000 | +63.7% | 4,791,179 | +20.8% | 0.75% | +17.7% |
Q2 2013 | $32,047,000 | – | 3,966,179 | – | 0.63% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |